Biotech · Private company
Ankyra Therapeutics, Inc
Track this companyFree. Adds Ankyra Therapeutics, Inc to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- CemiplimabPhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- CetrelimabPhase 1 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- tolododekin alfaPhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- tolododekin alfaPhase 1 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung CancerPHASE1 · RECRUITING · started Oct 22, 2025ClinicalTrials.gov NCT07027514 · fetched Nov 12, 2026
- Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid TumorsPHASE1 · RECRUITING · started Jan 19, 2024ClinicalTrials.gov NCT06171750 · fetched Nov 12, 2026